The following research lines reflect the center’s priority areas in biomedicine and health:
New technologies for biomimetic organ and tissue models
Development of biomaterials, 3D bioprinting techniques, biosensors, stem cells, nanotechnologies, tissue engineering processes, and organ-on-a-chip devices to create innovative tissue models (skin, intestine, blood-brain barrier, liver, kidneys, spleen, heart).
New technologies for sensors and electronic devices
Design of biosensors and microdevices, advanced processing techniques, and algorithms for interpreting biomedical signals to improve diagnosis and patient monitoring throughout therapeutic interventions.
New technologies for personalized medicine therapeutic strategies
Microscopy, modeling, biomodels, microfluidics, and nanotechnologies for innovative solutions to fertility issues and cancer treatment, particularly immunotherapies.
New technologies for biological model production and validation
Cultivation of primary cells and organotypic models (organoids, spheroids, tumoroids), including bioreactors capable of in situ monitoring of cell growth, ensuring highly reproducible processes.
New technologies in bioinformatics and data analysis
Development of tools for the analysis of biomedical, genetic, proteomic, metabolomic, and physiological signals, supported by advanced signal processing and artificial intelligence.